{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:29:51Z","timestamp":1788348591455,"version":"build-2803163510"},"reference-count":23,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>VWFpp\/VWF:Ag and FVIII:C\/VWF:Ag ratios define the pathophysiological mechanisms that play a role in VWD and various VWF mutations. A high VWFpp\/VWF:Ag ratio indicates increased clearance of VWF and a high FVIII:C\/VWF:Ag ratio decreased synthesis of VWF.<\/jats:p>","DOI":"10.1182\/blood-2012-09-455089","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T00:17:07Z","timestamp":1359073027000},"page":"2336-2339","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":97,"title":["VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease"],"prefix":"10.1182","volume":"121","author":[{"given":"Jeroen","family":"Eikenboom","sequence":"first","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto B.","family":"Federici","sequence":"additional","affiliation":[{"name":"AB Bonomi Hemophilia and Thrombosis Centre, Foundation IRCCS Ca\u2019 Granda Maggiore Policlinico Hospital and University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Dirven","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[{"name":"Hematology Department, San Bortolo Hospital, Vicenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rodeghiero","sequence":"additional","affiliation":[{"name":"Hematology Department, San Bortolo Hospital, Vicenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[{"name":"H\u00e4mostaseology, Medilys Laborgesellschaft mbH, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Schneppenheim","sequence":"additional","affiliation":[{"name":"University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Batlle","sequence":"additional","affiliation":[{"name":"Servicio de Hematologia y Hemoterapia, Hospital Teresa Herrera, La Coruna, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Canciani","sequence":"additional","affiliation":[{"name":"AB Bonomi Hemophilia and Thrombosis Centre, Foundation IRCCS Ca\u2019 Granda Maggiore Policlinico Hospital and University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[{"name":"University of Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Peake","sequence":"additional","affiliation":[{"name":"Haemostasis Research Group, Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Goodeve","sequence":"additional","affiliation":[{"name":"Haemostasis Research Group, Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the MCMDM-1VWD Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111816042734900_B1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111816042734900_B2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor.","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"2019111816042734900_B3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1073\/pnas.84.7.1955","article-title":"Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.","volume":"84","author":"Wagner","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111816042734900_B4","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2019111816042734900_B5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1655973","article-title":"Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.","volume":"77","author":"Vischer","year":"1997","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111816042734900_B6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V94.1.179.413k18_179_185","article-title":"von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation.","volume":"94","author":"van Mourik","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2019111816042734900_B7","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","article-title":"von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.","volume":"4","author":"Nossent","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111816042734900_B8","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111816042734900_B9","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance.","volume":"3","author":"Schooten","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111816042734900_B10","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2019111816042734900_B11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0002-9343(76)90750-6","article-title":"Diagnosis of von Willebrand\u2019s disease. A comparative study of diagnostic tests on nine families with von Willebrand\u2019s disease and its differential diagnosis from hemophilia and thrombocytopathy.","volume":"60","author":"Lian","year":"1976","journal-title":"Am J Med"},{"issue":"1","key":"2019111816042734900_B12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.V54.1.137.bloodjournal541137","article-title":"Genetics of classic von Willebrand\u2019s disease. II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis.","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"issue":"2","key":"2019111816042734900_B13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0037-1612981","article-title":"The factor VIII\/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.","volume":"87","author":"Eikenboom","year":"2002","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111816042734900_B14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111816042734900_B15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111816042734900_B16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111816042734900_B17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1538-7836.2007.02444.x","article-title":"Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).","volume":"5","author":"Tosetto","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111816042734900_B18","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111816042734900_B19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111816042734900_B20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2009.03486.x","article-title":"Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.","volume":"7","author":"Eikenboom","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111816042734900_B21","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3324\/haematol.2010.027177","article-title":"Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort.","volume":"95","author":"Hampshire","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"2019111816042734900_B22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.blre.2005.02.002","article-title":"Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease.","volume":"20","author":"Millar","year":"2006","journal-title":"Blood Rev"},{"issue":"4","key":"2019111816042734900_B23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1160\/TH06-09-0549","article-title":"ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.","volume":"97","author":"Morelli","year":"2007","journal-title":"Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/12\/2336\/1364714\/2336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/12\/2336\/1364714\/2336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:05:11Z","timestamp":1574093111000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/12\/2336\/31458\/VWF-propeptide-and-ratios-between-VWF-VWF"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,21]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-09-455089","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718285143.793491263","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,21]]}}}